Additional warnings to be put in sales of 134 drugs

The Korea Food and Drug Administration said on Tuesday that it instructed 79 pharmaceutical companies to add the warnings to the instructions of 134 medicinal products. Among the relevant products are Ofloxacin, lomefloxacin, gonadotropin-releasing hormone (GnRH) agonists and orlistat.

The instruction follows similar action by the U.S. Food and Drug Administration which has recently issued ...